Sugi Predict

Sugi Predict / Compounds / SCHEMBL25818453

SCHEMBL25818453

SCHEMBL25818453

Clc1nc(-c2cccc(-c3ccc4ccc(-c5ccc6ccccc6c5)cc4c3)c2)nc(-c2ccc3c(c2)sc2ccccc23)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ HSD17B2 P37059 1/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35
▸ CYP11B2 P19099 1/20 0.35
▸ GPR3 P46089 1/20 0.34
▸ RPA1 P27694 1/20 0.34
▸ CYP1A2 P05177 3/20 0.33
▸ CYP1A1 P04798 2/20 0.33
▸ CYP1B1 Q16678 2/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ SIRT2 Q8IXJ6 4/20 0.33
▸ S1PR5 Q9H228 2/20 0.33
▸ MCL1 Q07820 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818423 0.95 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL25818529 0.94 ALDH1A1 (0.34) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL25818432 0.94 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL23285612 0.94 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL25817750 0.94 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL30855549 0.94 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL23518911 0.92 SMN1; SMN2 (0.41) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL25818482 0.92 S1PR5 (0.39) ALDH1A1SMN1; SMN2MAPTHPGDRAB9A
SCHEMBL22161533 0.91 HSD17B1 (0.37) ALDH1A1SMN1; SMN2HSD17B1HSD17B2CYP17A1
SCHEMBL25818441 0.91 HSD17B1 (0.37) ALDH1A1SMN1; SMN2HSD17B1HSD17B2CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885SMN1; SMN2 474/4885MAPT 679/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885SMN1; SMN2 474/4885MAPT 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.